Study of myMS in Participants With a Diagnosis of Multiple Sclerosis
A Pilot Study Evaluating the Feasibility of A Mobile Application to Collect Clinical, Magnetic Resonance Imaging Information and Genetic Data in Participants With Multiple Sclerosis
1 other identifier
observational
200
1 country
1
Brief Summary
This is a pilot study looking at the feasibility of a mobile application (app) to collect data from active tasks (questionnaires, 6Mapp™, COGapp™, VISapp™), clinical magnetic resonance imaging information and conduct genome-wide association studies in subjects with multiple sclerosis. Participants will be self-referred to this study from different sources; patient advocacy groups, social media tools, clinicaltrials.gov, and flyers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2017
CompletedFirst Posted
Study publicly available on registry
April 12, 2017
CompletedStudy Start
First participant enrolled
April 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 25, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 25, 2021
CompletedNovember 26, 2021
November 1, 2021
4.6 years
March 15, 2017
November 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Participants willing to provide genetic and MRI data via myMS
Proportion of participants with both genetic and MRI data available
12 months
Eligibility Criteria
Participants with a diagnosis of Multiple Sclerosis.
You may qualify if:
- Males or females participants with access to an iPhone 5 and above.
- Participants willing to provide electronic consent.
- Age 18 and above.
- A diagnosis of MS (Polman, 2010), with dissemination in time and space. CIS participants will be included if they fulfil 3 of the 4 MRI criteria for dissemination in space as per Polman et al. 2010.
- EDSS of between 0 and 8.0
You may not qualify if:
- Under 18 years of age
- Participants who do not consent to participate.
- Participants participating in ongoing MS clinical trials with non-approved drugs.
- Any concurrent illness, disability or clinically significant abnormality (including laboratory tests) that may prevent the subject from safely completing the assessments required by the protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aimslab@Usc.Edu
Los Angeles, California, 90033, United States
Biospecimen
Saliva samples are collected for DNA analysis
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Pelletier, M.D.
Keck School of Medicine of USC, University of Southern California
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Neurology; Vice Chair, Clinical Research, Department of Neurology; Division Chief, Neuro-Immunology and USC Multiple Sclerosis Center
Study Record Dates
First Submitted
March 15, 2017
First Posted
April 12, 2017
Study Start
April 17, 2017
Primary Completion
November 25, 2021
Study Completion
November 25, 2021
Last Updated
November 26, 2021
Record last verified: 2021-11